140 likes | 375 Views
Adoption of Evidence-based Practices in Addiction Treatment. J. Aaron Johnson, Ph.D. Center for Research on Behavioral Health and Human Services Delivery The University of Georgia. Background.
E N D
Adoption of Evidence-basedPractices in Addiction Treatment J. Aaron Johnson, Ph.D. Center for Research on Behavioral Health and Human Services Delivery The University of Georgia Funded by National Institute on Drug Abuse and Robert Wood Johnson Foundation
Background • Concern about adoption and implementation of “evidence-based practices” in addiction treatment field - “research to practice gap” • Substantial resources devoted to development of treatment techniques, including medications and psycho-social approaches • Substantial resources devoted to “bridging” gap – NIDA CTN, SAMHSA ATTC’s, RWJF Initiatives, etc. • Environmental constraints, organizational barriers to innovation adoption • Our research – devoted to identifying barriers as well as factors facilitating adoption Funded by National Institute on Drug Abuse and Robert Wood Johnson Foundation
Research Question • To what extent does the addiction treatment field use evidence-based practices and how does use of EBPs vary across different types of programs? • What are the longitudinal trends in the adoption of EBPs in addiction treatment? Funded by National Institute on Drug Abuse and Robert Wood Johnson Foundation
The National Treatment Center Study • Monitoring the organization, management, delivery, and content of addiction treatment in the U.S. • Includes Nationally Representative Samples of: • Privately-funded treatment programs (N=401) • Publicly-funded treatment programs (N=362) • Programs must offer a level of care for addiction treatment at least equivalent to structured outpatient as defined by ASAM • Excludes: methadone maintenance-only facilities, clinicians in private practice, DUI-only programs, halfway houses Funded by National Institute on Drug Abuse and Robert Wood Johnson Foundation
NTCS Instrument Design • Multiple data collection methods used: • Detailed on-site interviews with program administrator • Focus - organizational characteristics, services offered, and use of innovations • Mail questionnaire from program administrator • Focus - leadership and management practices • Mail questionnaire from counselors • Focus - services received by clients and attitudes toward innovations • Brief telephone follow-ups w/ program administrator at six month intervals • Focus - changes within the center including adoption of new EBPs • Current analyses - on-site interviews and telephone follow-ups collected between June 2000 and September 2005 • Private programs – up to seven data points • Public programs – three data points (Funding began in 2002) Funded by National Institute on Drug Abuse and Robert Wood Johnson Foundation
Defining Programs by Funding/Ownership • Public centers are defined as: • Offering at least one level of care equivalent to structured outpatient tx • Receiving at least 50% of their revenues from governmental block grants and/or governmental contracts • Programs may be of two types: government-owned entities or non-profit organizations • Private centers are defined as: • Offering at least one level of care equivalent to structured outpatient tx • Receiving less than 50% of their revenues from governmental block grants and/or governmental contracts • Programs may be of two types: non-profit or for profit organizations Funded by National Institute on Drug Abuse and Robert Wood Johnson Foundation
Distribution of Programs in Sample Funded by National Institute on Drug Abuse and Robert Wood Johnson Foundation
Defining Evidence-based Practices • Evidence-based Practices - addiction treatment techniques that have been shown through a series of clinical trials to have a positive impact on treatment outcome. • Results from four common pharmaco-therapies and five behavioral therapies. Derived from NIDA’s Principles of Drug Abuse Treatment. Funded by National Institute on Drug Abuse and Robert Wood Johnson Foundation
Use of Selected EBPs by Program Type(On-site interviews - July 2002 – Jan. 2004) Funded by National Institute on Drug Abuse and Robert Wood Johnson Foundation
Funded by National Institute on Drug Abuse and Robert Wood Johnson Foundation
Funded by National Institute on Drug Abuse and Robert Wood Johnson Foundation
Funded by National Institute on Drug Abuse and Robert Wood Johnson Foundation
Funded by National Institute on Drug Abuse and Robert Wood Johnson Foundation
Conclusions • Significant public/private differences with private programs more likely to use pharmaco-therapies. More likely based in hospital = more access to medical staff • Rather than increasing, there has been steady decline in use of antabuse and naltrexone. Possible explanation = difficulties associated with compliance. Possible solution = Injectable naltrexone • Adoption of buprenorphine promising. Trend line shows steady increase since approval in October 2002 • Generic names make measuring “adoption” of behavioral therapies difficult. Now trying to measure fidelity. Funded by National Institute on Drug Abuse and Robert Wood Johnson Foundation